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P01.059 RATES OF SEASONAL CHANGES IN CLINICAL
STATUS OF BIPOLAR DISORDER PATIENTS IN THE
STEP-BD 1000 DATA SET
E. Friedman1, M. Bhargava1, S. Wisniewski1, M. Landen2, M. Thase1.
1University of Pittsburgh Medical Center, USA; 2Institutionen for klinisk Neu-
rovetenskapSahlgrenska Universitetssjukhuset/Molndal, Sweden
Statement of the Study: Patients with bipolar disorder are assumed to have an
increased sensitivity to light. Evidence for this hypothesis includes changes in
seasonal rates of mania (1), depression (2) and suicidality (3).
Methods: We examined the first 1000 patients enrolled in the Systematic
Treatment Enhancement Program – Bipolar Disorder (STEP-BD) study. Patients
who achieved Recovered status were examined for the prevalence of change, by
month, to a new clinical status (Depression, Mania, Hypomania, Mixed) over the
course of one year.
Summary of Results: There were 19,841 total reported changes in clinical
status: 4,775 for bipolar II disorder (24.07%) and 14,017 for bipolar I disorder
(70.64%).
Prevalence of change in clinical status from syndromal remission
Month(s) of Highest Prevalence (%) Month(s) of Lowest Prevalence (%)
Total Population
Depression April (9.56) June (7.06)
Mania March and December (10.48) June (5.68)
Hypomania April (10.81) October (6.98)
Mixed April and May (9.72) August and September (7.71)
Bipolar I
Depression April and May (9.39) June (7.08)
Mania March (10.93) August (5.46)
Hypomania April and May (11.6) December (6.44)
Mixed April and May (9.75) September (7.04)
Bipolar II
Depression May (10.41) June (7.08)
Mania April (10.82) and December (12.86) August (5.46)
Hypomania April (10.84) September and October (6.40)
Mixed April (10.43) August (6.09)
Conclusion: This data in bipolar patients confirms patterns of peaks in
prevalence of new onset episodes of illness in early spring, along with another
peak of mania in December for bipolar II and in February for bipolar I.
Interestingly, the summertime rates of depression, mania, and mixed status were
troughs, with a fall-winter trough in the hypomanic patients. These results are
consistent with the hypotheses of vulnerability to the illness around the solstices
(March 21 and September 21) and the shortest photoperiod (December). The data
also suggests seasonal influences affect mood stability rather than the polarity
of the mood episode.
Funding: NIMH
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P01.060 CYCLOTHYMIC TEMPERAMENT AND DEPRESSIVE
DISORDERS: CLINICAL FEATURES AND FAMILY
HISTORY
G. Rosso, U. Albert, V. Salvi, G. Maina, F. Bogetto. University of Turin, Italy
Statement of the Study: Recent research on affective disorders suggest that
a major depressive disorder (MDD) in patients with cyclothymic temperament
(CT) might be included in a broad bipolar spectrum (Akiskal & Mallya, 1987),
as well as MDD plus antidepressant-associated hypomania or superimposed on
hyperthymic temperament (bipolar III and IV) (Akiskal et al., 2003; Cassano et
al., 1992). Their likelihood to belong to the bipolar spectrum had previously been
confirmed by an earlier age at onset of the affective disorder and by a higher
rate of bipolar familiality, while such results had not been confirmed for MDD
+ CT as well. Aim of this study was to determine whether depressed unipolar
patients with cyclothymic temperament were different from depressed patients
that do not exhibit any dominant temperament, by comparing clinical and family
history features.
Methods: A sample of unipolar outpatients (DSM-IV-TR, SCID), consec-
utively referred to our unit were administered the Semi-structured Clinical
Interview for Temperament (TEMPS-I) (Placidi et al, 1998) and the Family
History Questionnaire. Patients with dysthymic disorder and depressive disorder
not otherwise specified were excluded from further data analysis. Age at onset of
MDD and familial history for bipolar disorder were compared between patients
with or without CT using respectively Student’s t-test and c2 test.
Summary of Results: 87 out of 104 depressed patients were affected by MDD;
of these, 60(69.0%) did not show any dominant temperament, while 13(14.9%)
had cyclothymic temperament, 4(4.6%) hyperthymic, 2(2.3%) irritable, and
8(9.2%) depressed temperament. When clustering patients according to the pres-
ence/absence of CT, we found that the former group was significantly younger
at onset of MDD (41.0± 15.2 vs. 51.5± 15.5 years; p=0.026); bipolar familiality
was significantly higher in the MDD + CT group (15.4% vs 1.4%; p=0.011).
Furthermore, in order to avoid the confounding effect of other temperaments on
age at onset and on familiality, we decided to rule out those with temperament
other than cyclothymic. Cyclothymic patients had a statistically significant earlier
age at onset than depressives without any dominant temperament (41.0± 15.2
vs. 52.7± 14.5 years; p=0.011); furthermore they had significantly more bipolar
family history (15.4% vs. 0%; p=0.002).
Conclusion: The earlier onset of MDD in patients with CT, as well as the high
rate of familiality, strive for an inclusion in a broad bipolar spectrum, pointing
towards the validation of the subtype of bipolar disorder that Akiskal has labeled
as bipolar II. These preliminary data deserve further confirmation through better
controlled studies.
P01.061 TREATMENT PSYCHOTIC SYMPTOMS IN CHILDREN
WITH BIPOLAR DISORDER
E. Mick. Harvard Medical School, USA
Statement of the Study: The purpose of this presentation to study secondary
outcomes, specifically associated psychotic behavior, from our open label trials of
atypical neuroleptics in the treatment of children and adolescents with pediatric
bipolar disorder
Methods: This was a single-site, prospective, open-label, eight-week study of
risperidone or olanzapine monotherapy in the treatment of youth with mania,
aimed at evaluating short-term safety and efficacy, and time course of treatment
response of the medication. Psychotic symptoms were evaluated with the Brief
Psychiatric Rating Scale which was assessed at Week 0, 4 and 8.
Summary of Results: There were 30 males (13 on olanzapine and 17 on
risperidone) and 18 females (5 on olanzapine and 13 on risperidone) with
a mean age of 8.9± 2.7 years. There was a statically significant reduction
of 12 points (F(2,119)=34.1, p<0.0001)on the BPRS over the course of the
trial that did not differ between risperidone and olanzapine treated subjects
(t = −0.45, p=0.6). There were significant improvements for the Thought Disorder
(p<0.001), Anxiety/Depression (p< 0.009), and Hostility (p<0.001) factors of the
BPRS that did respond to one medication preferentially.
Conclusion: This study shows that, in addition to be effective in managing
bipolar symptomatology, risperidone and olanzapine may also be effective in
treating psychotic symptomatology.
P01.062 HYPOMANIA AND MANIA HAVE DIFFERENT SYMPTOM
PROFILES
A. Serretti, P. Olgiati. S. Raffaele Hospital, Italy
Statement of the Study: According to DSM IV, manic and hypomanic episodes
differ only in the degree of severity. Yet several lines of evidence, including
family history, long-term diagnostic stability and linkage studies, point to bipolar
I (BP-I) and bipolar II (BP-II) disorders as having distinct forms. This suggests
that mania and hypomania, which are the hallmarks of the two disorders, might
have different symptom profiles. To test this hypothesis we compared manic
symptoms occurring in two BP-I and BP-II groups.
Methods: Two hundred and eighty bipolar inpatients were assessed using the
Operational Criteria for psychotic illness checklist with a lifetime perspective.
Manic or hypomanic symptoms were investigated and compared between BP-I
(N=158) and BP-II (N=122).
Summary of Results: When compared with BP-II, BP-I disorder had a higher
prevalence of reckless activity, distractibility, psychomotor agitation, irritable
mood and increased self-esteem. These five symptoms correctly classified 82.8%
of BP-I and 80.1% of BP-II patients.
Conclusion: These findings suggest that mania and hypomania can be dif-
ferentiated in their clinical profiles and serve to address the question of bipolar
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